AptaBio Therapeutics Revenue

AptaBio Therapeutics had revenue of 1.60B KRW in the quarter ending June 30, 2026, with 42.81% growth. This brings the company's revenue in the last twelve months to 4.75B, up 52.91% year-over-year. In the year 2025, AptaBio Therapeutics had annual revenue of 3.70B with 10.02% growth.

Revenue (ttm)

4.75B

Revenue Growth

+52.91%

P/S Ratio

38.18

Revenue / Employee

n/a

Employees

n/a

Market Cap

181.48B

Revenue Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.70B	336.93M	10.02%
Dec 31, 2024	3.36B	3.04B	937.76%
Dec 31, 2023	323.87M	275.52M	569.80%
Dec 31, 2022	48.35M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.